NASDAQ:PFSA Profusa (PFSA) Stock Price, News & Analysis $1.42 -0.07 (-4.70%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$1.48 +0.06 (+3.87%) As of 10/9/2026 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsSEC Filings About Profusa Stock (NASDAQ:PFSA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Profusa alerts:Sign Up Key Stats Today's Range$1.40▼$1.5350-Day Range$1.42▼$27.4852-Week Range$1.40▼$3,000.00Volume231,698 shsAverage Volume5.30 million shsMarket Capitalization$866.20 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Profusa, Inc. is a biotechnology company developing implantable biosensor technology designed to continuously monitor body chemistry. Its sensors are engineered to integrate with tissue and detect selected biological signals, with the goal of providing real-time health data through an external reader or connected digital device. The company’s technology platform has been studied for applications including monitoring oxygen and other biomarkers that may assist with disease management, clinical research, and personalized healthcare. Profusa has also developed the Lumee oxygen-sensing system and has explored additional uses for its biosensors in areas such as chronic-condition monitoring and remote patient care. Profusa’s work has included collaborations and research programs involving government and healthcare organizations. The company’s technology remains focused on developing less invasive, continuous monitoring solutions that could complement conventional laboratory testing and periodic measurements.AI Generated. May Contain Errors. Read More Profusa Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScorePFSA MarketRank™: Profusa scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingProfusa has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageProfusa has only been the subject of 1 research reports in the past 90 days.Read more about Profusa's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted31.19% of the float of Profusa has been sold short.Short Interest Ratio / Days to CoverProfusa has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Profusa has recently increased by 409.28%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldProfusa does not currently pay a dividend.Dividend GrowthProfusa does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Profusa this week, compared to 3 articles on an average week.Search Interest8 people have searched for PFSA on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Profusa insiders have sold 127.45% more of their company's stock than they have bought. Specifically, they have bought $16,594.00 in company stock and sold $37,743.00 in company stock.Percentage Held by Insiders15.00% of the stock of Profusa is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions9.81% of the stock of Profusa is held by institutions.Read more about Profusa's insider trading history. Receive PFSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profusa and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PFSA Stock News HeadlinesProfusa Announces Significant Progress towards Lumee Oxygen Platform CE Mark with ISO 13485 certification Expected in Early OctoberSeptember 25, 2026 | marketscreener.comMHere’s What Investors Are Watching, Including $20 Price Target BombshellSeptember 24, 2026 | markets.businessinsider.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 10 at 1:00 AM | Banyan Hill Publishing (Ad)Profusa ISO 13485 certification decision advances Lumee oxygen platform toward CE markSeptember 24, 2026 | msn.comMicro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring TechSeptember 24, 2026 | benzinga.comProfusa Advances Lumee Oxygen Platform Toward CE MarkSeptember 24, 2026 | rttnews.comProfusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early OctoberSeptember 24, 2026 | globenewswire.comProfusa Receives Nasdaq Confirmation Of Compliance ;Shares SlideSeptember 15, 2026 | rttnews.comSee More Headlines PFSA Stock Analysis - Frequently Asked Questions How have PFSA shares performed this year? Profusa's stock was trading at $786.00 on January 1st, 2026. Since then, PFSA shares have decreased by 99.8% and is now trading at $1.42. How were Profusa's earnings last quarter? Profusa, Inc. (NASDAQ:PFSA) issued its earnings results on Wednesday, August, 19th. The company reported ($151.80) earnings per share for the quarter. When did Profusa's stock split? Profusa shares reverse split on Monday, February 9th 2026.The 1-75 reverse split was announced on Thursday, February 5th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 6th 2026. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of Profusa? Shares of PFSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/19/2026Today10/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PFSA's financial health is in the Yellow zone, according to TradeSmith. PFSA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:PFSA CIK1859807 Webprofusa.com Phone(212) 494-9022FaxN/AEmployees2Year Founded2009Profitability EPS (Trailing Twelve Months)($5,619.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.82 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,731.09% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual Sales$100 thousand Price / Sales8.66 Cash FlowN/A Price / Cash FlowN/A Book Value($2,168.90) per share Price / Book0.00Miscellaneous Outstanding Shares610,000Free Float515,000Market Cap$866.20 thousand OptionableN/A Beta0.53 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:PFSA) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profusa, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profusa With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
